By Debdeep Gupta | July, 02 2025
Lupin shares gain on USFDA approval for Loteprednol Etabonate Ophthalmic gel
lupin share price gained in the early trade on july 2 on the back of usfda approval for loteprednol etabonate ophthalmic gel.at 09:20am, lupin was quoting at rs 1,969.70, up rs 8.40, or 0.43 percent, on the bse." ...... has received approval from the united states food and drug administration (usfda) for its abbreviated new drug application for loteprednol etabonate ophthalmic gel, 0.38%," company said in the exchange filing.loteprednol etabonate